Synbio International has signed a strategic licensing and revenue-sharing agreement with MD PHD Wellness to exclusively commercialize MD PHD's proprietary nutraceutical products in the US and Canada. This deal accelerates Synbio's revenue path by granting immediate access to established wellness formulations, including an anti-anxiety product under Synbio's Healing Force™ brand. MD PHD Wellness will handle product development and manufacturing, while Synbio focuses on branding, marketing, and sales. The partnership supports Synbio's strategy to build a diversified healthcare company combining near-term nutraceutical revenue with long-term AI-driven mental health technology development.
Apple reported its strongest June quarter ever with revenue of $109.42 billion, up 16.36% year-over-year, and earnings per share of $2.02, beating expectations for the ninth consecutive quarter. Key growth drivers include a $54 billion hardware segme...
Strategy, led by Michael Saylor, purchased 4,603 Bitcoin at an average price of $80,318 each in late August 2026, increasing its total Bitcoin holdings to 845,050 BTC. This marks the company's first Bitcoin purchase in 10 weeks after selling nearly 7...
Circle announced it will acquire Singapore-based Tazapay, a B2B cross-border payments company, to enhance adoption of its USDC stablecoin. The acquisition leverages Tazapay's extensive banking network and payout infrastructure across over 100 markets...
Dell Technologies and NVIDIA both reported strong AI-driven revenue growth in Q2 FY27, with Dell posting $46.97 billion revenue and NVIDIA $96.22 billion. While NVIDIA dominates as the AI compute platform owner with high margins, Dell is gaining grou...
Chevron benefits directly from the Iran conflict and rising prices for oil and related commodities, with global reserves at critical lows. Its Project Kilby will monetize Permian Basin natural gas by powering a large Microsoft AI data center under a ...
